Molecular Mechanisms of MYCN Dysregulation in Cancers
Authors:
Open Access
- 3 February 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10
Abstract
MYCN, a member of MYC proto-oncogene family, encodes a basic helix-loop-helix transcription factor N-MYC. Abnormal expression of N-MYC is correlated with high-risk cancers and poor prognosis. Initially identified as an amplified oncogene in neuroblastoma in 1983, the oncogenic effect of N-MYC is expanded to multiple neuronal and nonneuronal tumors. Direct targeting N-MYC remains challenge due to its “undruggable” features. Therefore, alternative therapeutic approaches for targeting MYCN-driven tumors have been focused on the disruption of transcription, translation, protein stability as well as synthetic lethality of MYCN. In this review, we summarize the latest advances in understanding the molecular mechanisms of MYCN dysregulation in cancers.Keywords
Funding Information
- National Key Research and Development Program of China (2016YFC1302204)
- National Natural Science Foundation of China (81872071)
- Natural Science Foundation of Chongqing Municipality
This publication has 166 references indexed in Scilit:
- ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine DeprivationCancer Cell, 2012
- Dissecting the genomic complexity underlying medulloblastomaNature, 2012
- MYC on the Path to CancerCell, 2012
- Activated ALK Collaborates with MYCN in Neuroblastoma PathogenesisCancer Cell, 2012
- A Mouse Model of the Most Aggressive Subgroup of Human MedulloblastomaCancer Cell, 2012
- Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastomaBritish Journal of Cancer, 2011
- Selective inhibition of BET bromodomainsNature, 2010
- Establishing, maintaining and modifying DNA methylation patterns in plants and animalsNature Reviews Genetics, 2010
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoproteinNature Cell Biology, 2008